Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In radiation oncology, the best way to maintain patient safety when implementing cutting edge technologies such as AI-based and real-time adaptive techniques is through prospective hazard analysis.

Physical and engineering sciences in medicine·2026
Same author

The Role of Generative Artificial Intelligence in the Analysis of Qualitative Data Compared With Human-Led Analysis.

Cureus·2026
Same author

Persona-Driven Vignettes: A Novel Needs Assessment and Audit Tool for Faculty Development.

Cureus·2026
Same author

The Structure of the Full Catalytic Cycle of Vibrio cholerae NFeoB.

Journal of molecular biology·2026
Same author

An open-source motion platform that replicates time synchronised internal and external patient motion for real-time image-guided radiotherapy.

Physical and engineering sciences in medicine·2026
Same author

Implementation of Virtual Reality for Postoperative Recovery in an Adolescent Idiopathic Scoliosis Population: A Prospective Pilot Study.

Pediatric neurosurgery·2026
Same journal

Systemic Amyloidosis: A Clinical Challenge from the Palliative Care Perspective.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

Cancer Patients with Neuropathic Pain: Pharmacist-Led Recommendation and Management and Mirogabalin Outcomes in a Single-Center Retrospective Observational Cohort.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

Cost-Effectiveness of Integrative Pain Management for Chronic Pain: A Systematic Review of Economic Evaluation.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

High-Dose Monotherapy or Combination Therapy in Neuropathic Pain: A Necessary Reflection.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

The Price of Goodbye.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

In the End, What Shall We Say?

Journal of pain & palliative care pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.2K

Case Report: Sublingual Levodopa in Advanced Multiple System Atrophy.

Monica De Leon1,2, Mark Lee1, Jonathan Hindmarsh1,2

  • 1Specialist Centre for Palliative Care, St. Benedict's Hospice, Sunderland, United Kingdom.

Journal of Pain & Palliative Care Pharmacotherapy
|April 30, 2026
PubMed
Summary
This summary is machine-generated.

Sublingual co-beneldopa offers a novel solution for Multiple System Atrophy (MSA) patients experiencing motor fluctuations due to gastrointestinal absorption issues. This approach effectively managed severe "off" episodes when standard levodopa failed.

Keywords:
Levodopamultiple system atrophysublingual

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K
Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
07:45

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

Published on: December 1, 2023

1.5K

Related Experiment Videos

Last Updated: May 2, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.6K
Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
07:45

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

Published on: December 1, 2023

1.5K

Area of Science:

  • Neurodegenerative diseases
  • Pharmacology
  • Gastroenterology

Background:

  • Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder.
  • Parkinsonism and autonomic dysfunction are key features of MSA.
  • Advanced MSA often involves dysphagia and gastric dysmotility, impairing oral medication absorption.

Purpose of the Study:

  • To report a novel administration route for levodopa in advanced MSA.
  • To evaluate the efficacy of sublingual co-beneldopa in managing motor "off" episodes.
  • To explore alternative therapeutic strategies when enteral levodopa fails.

Main Methods:

  • Case report of an advanced MSA patient.
  • Administration of sublingual co-beneldopa.
  • Assessment of motor symptom relief and patient comfort.

Main Results:

  • Sublingual co-beneldopa provided rapid and reliable relief from severe motor "off" episodes.
  • This method bypassed compromised gastrointestinal absorption.
  • Improved symptom control and enhanced patient comfort were observed.

Conclusions:

  • Sublingual levodopa is a viable alternative for MSA patients with enteral absorption difficulties.
  • This approach offers improved symptom management in a palliative care setting.
  • Further research is needed to confirm efficacy and safety.